In colon cancer, MSI-1 expression and epithelial growth factor pathway activity were correlated [28], the latter being another key regulator of radioresistance that is specifically targeted in radiation-centered clinical trials [29]. This evidence concerns the gene MSI1 and malignant colon neoplasm.